See article by Gao et al. [1] ( pages 197 -204) in this
to achieve cardiac-specific conditional gene expression in issue.
the heart [30, 31] . As shown in Fig. 1 , this system requires two lines of transgenic mice: one expressing a chimeric Manipulation of the mouse genome by transgenic aptet-regulateable transcriptional activator (tTA) in a cardiacproaches is a powerful tool to examine gene function as specific manner, and another carrying the target gene well as interaction of gene products in the intact animal driven by a quiescent minimal cytomegaly virus promoter [2] [3] [4] . In the past, gain-in-function models were the most (CMV ) which is flanked by multimerized copies of the min frequently used transgenic animals to define the physiologtet operator sequences (tetO). By crossbreeding, doubleical relevance of gene products. In these animals, transgene transgenic progenies that harbour both regulatory elements expression is controlled by well characterized promoter are generated in which the transgene is expressed in the elements that drive transgene expression by their cardioabsence of tet but not in its presence (tet-off system). specificity, while the onset of transgene expression deTaking advantage of the modular composition of most pends on the temporal activation of the promotor employed transcription factors, the transcriptional repression domain [5] [6] [7] [8] [9] [10] [11] . However, the temporal regulation of transgene of the tet repressor has been replaced by a strong transactiexpression might prevent investigation of a number of vation domain from the transcription factor VP16 of herpes important questions. In its worst case, the inappropriate simplex virus (HSV), while the DNA-and tet-binding onset of transgene expression can interfere with proper domain have been retained. The resulting chimeric tranembryonal development resulting in early lethal scription factor (tTA), thus converted to a ligand-regulated phenotypes [12] [13] [14] . Less dramatically but more commontransactivator, binds to the tetO sequences in the absence ly, constitutive transcriptional activity of the promoter does but not in the presence of tet. Subsequently, this protein not provide any information on developmental aspects of strongly activates, rather than represses, transcription transgene expression [15] [16] [17] and prevents examination of promoters including tetO sequences. Recently, the efficacy the gene dosis and phenotype [18, 19] . These limitations of this binary system has been successfully tested in the are overcome by conditional transgenic systems allowing heart by Yu el al. [31] . control of the timing as well as the spatial pattern of gene
In the current issue of Cardiovascular Research, Gao et expression (for reviews, see Refs. [20, 21] agent for heart failure, the study demonstrates for the first time a ligand-controlled genetic manipulation of the heart that results in a reversible positive inotropic effect of a target gene in vivo. Now, by crossbreeding their conditional AC transgene with a myopathic transgenic they VI could evaluate the effects of AC when signs of heart VI failure are already present. It is noteworthy that AC VI overexpression mediated enhanced 'recruitable' cAMP responsiveness without sustained adrenergic activation which might account for the marked differences in phenotype when compared to the effects of prolonged over- of cardiovascular gene therapy. The exciting question of the therapeutic potential of AC as a novel target to treat VI derivative were carefully controlled. Four days after rehuman heart failure is still unresolved but the study moves moval of tet suppression they first observed an increase of one significant step closer to the sought answer. myocardial AC protein content leading to a 10-fold VI cardiac-restricted increase in AC protein levels within 10 VI days. Subsequent reconstitution of tet suppression effec-R eferences tively abolished target gene expression. In vivo half-life of induced AC protein ranged from 2 to 3 days. Although 
